Exercise Study to Help Patients Who Have Type 2 Diabetes and Depression.
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT01024790
- Lead Sponsor
- University of Massachusetts, Worcester
- Brief Summary
The purpose of this study is to test an exercise treatment that includes behavioral strategies to improve blood sugar control in women with type 2 diabetes who are depressed and overweight.This research study may lead to a potentially useful treatment for diabetes management when depression is present.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 29
Inclusion Criteria
- Type 2 diabetes, depression, BMI <44,ages between 21-65, female
Exclusion Criteria
- BMI >44, >100 min. of exercise per week, Type 1 diabetes, no diabetes,MI,Stroke, Catheterization, unstable angina in previous 6 months,pregnancy,glucocorticosteroid therapy in last 3 months,bipolar, psychotic disorder or post-traumatic disorder,moving out of area within next 6 weeks
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method This research study may lead to a potentially useful treatment for diabetes management when depression is present. 6 weeks HbA1c 3-,6-, and 9-months Depression 3-, 6- and 9-months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link exercise to improved blood sugar control in type 2 diabetes patients with depression?
How does behavioral activation-enhanced exercise compare to standard exercise interventions in managing type 2 diabetes and depression?
Are there specific biomarkers that predict response to exercise-based interventions in overweight women with type 2 diabetes and depression?
What are the potential adverse events associated with behavioral activation-enhanced exercise in type 2 diabetes patients with depression?
What combination approaches or pharmacological agents could enhance the effectiveness of behavioral activation-enhanced exercise in treating type 2 diabetes and depression?
Trial Locations
- Locations (1)
University of Massachusetts Medical School
🇺🇸Worcester, Massachusetts, United States
University of Massachusetts Medical School🇺🇸Worcester, Massachusetts, United States